FIELD: biotechnology; chemistry.
SUBSTANCE: invention relates to biochemistry, particularly to an immunogenic composition containing an isolated O25b antigen. Disclosed is a vaccine containing said composition. Also disclosed is the use of said vaccine for treating an infection caused by the E.coli strain in a subject.
EFFECT: invention provides effective treatment of infection caused by Escherichia coli strain.
12 cl, 7 dwg, 2 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT ANTIBODY, PHARMACEUTICAL PREPARATION, DIAGNOSTIC PREPARATION, METHOD FOR IDENTIFYING CANDIDATE ANTIBODY, METHOD OF TREATING, PREVENTING AND DIAGNOSING SUBJECTS SUSCEPTIBLE TO RISK OF INFECTION OR SUFFERING INFECTIONS CAUSED BY MULTIDRUG-RESISTANT STRAINS OF E.COLI | 2014 |
|
RU2711512C2 |
| RECOVERED ANTIBODY (VERSIONS), A METHOD FOR PRODUCING THE ANTIBODY, AN ISOLATED NUCLEIC ACID, AN EXPRESSION CASSETTE (VERSIONS), A PLASMID (VERSIONS), A HOST CELL, A PHARMACEUTICAL PREPARATION, A KIT, A METHOD OF TREATING A PATIENT, AT RISK OF OR SUFFERING FROM ESCHERICHIA COLI INFECTION, AND A DIAGNOSTIC TECHNIQUE FOR DETERMINING ESCHERICHIA COLI INFECTIONS | 2014 |
|
RU2724530C2 |
| HUMANIZED TAU-ANTIBODY | 2013 |
|
RU2644242C2 |
| ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF | 2012 |
|
RU2658603C2 |
| ESCHERICHIA COLI COMPOSITIONS AND METHODS FOR THEIR APPLICATION | 2019 |
|
RU2788526C2 |
| MONOCLONAL ANTIBODIES AND METHODS FOR THEIR APPLICATION | 2012 |
|
RU2623122C2 |
| ANTIBODIES SPECIFIC TO CLAUDIN 6 (CLDN6) | 2010 |
|
RU2675997C2 |
| ANTIBODIES USEFUL IN DIAGNOSING CANCER | 2018 |
|
RU2815883C1 |
| ANTIBODIES TARGETING GALACTAN-BASED O-ANTIGEN FROM K.PNEUMONIAE | 2015 |
|
RU2759950C2 |
| ANTIBODIES AGAINST HUMAN IgG1 | 2011 |
|
RU2603284C2 |
